Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Progestin therapy for endometrial cancer can fail due to resistance. This study identifies p38-dependent phosphorylation of IDH1 as a key mechanism driving this resistance, offering a new therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Progestin therapy is a primary treatment for endometrial cancer, but resistance often develops.
- The molecular mechanisms driving progestin resistance remain incompletely understood.
Purpose Of The Study
- To elucidate the molecular basis of progestin resistance in endometrial cancer.
- To identify potential therapeutic targets to overcome progestin resistance.
Main Methods
- Investigated the effect of progestin on IDH1 phosphorylation and its subcellular localization.
- Examined the interaction between phosphorylated IDH1 (pT77-IDH1) and OCT6.
- Assessed the role of IDH1-produced α-ketoglutarate (αKG) in gene transcription.
- Evaluated the efficacy of pharmacological inhibition of p38 and focal adhesion signaling in vivo.
Main Results
- Progestin treatment induces p38-dependent phosphorylation of IDH1 at Threonine 77 (pT77-IDH1).
- pT77-IDH1 translocates to the nucleus and interacts with OCT6.
- IDH1-derived αKG enhances OCT6 activity, promoting transcription of focal adhesion-related genes and conferring progestin resistance.
- Inhibition of p38 or focal adhesion pathways sensitizes cancer cells to progestin therapy.
Conclusions
- p38-dependent pT77-IDH1 is a critical mediator of progestin resistance in endometrial cancer.
- Targeting p38 or focal adhesion signaling may improve progestin therapy efficacy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...